Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,730.00
Bid: 1,733.00
Ask: 1,733.50
Change: -16.50 (-0.94%)
Spread: 0.50 (0.029%)
Open: 1,748.50
High: 1,752.50
Low: 1,730.00
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Property Companies Get Indigestion

Fri, 13th Jun 2014 11:29

LONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osborne said he would give the central bank more power to curb mortgage lending.

There is already great speculation about the exact timing of the first rate hike and this decision is becoming more balanced, Carney said at the annual Mansion House dinner in London on Thursday evening. Osborne said his move to empower the bank was to limit risk to financial stability from the housing market.

Among the housebuilders, Persimmon was down 6.1%, Barratt Development, down 5.4%, Taylor Wimpey was down 7.1%, Berkeley Group Holdings down 6.1%, Bellway down 5.1% and Bovis Homes was down 4.7%, while Segro, down 4.0%, and Great Portland Estates, down 3.9%, were the worst hit of the real estate investment trusts.

The main London stock indices are again sharply lower due to increasing tensions in Iraq. Oil prices have risen again.

Sunni militants have captured at least one town in eastern Iraq, broadening their domination over portions of the country as they press south toward the capital Baghdad, reports said. Their lightning advances have sparked international fears that Iraq is falling apart, making room for the emergence of a radical enclave.

--------
FTSE 100: down 1.2% at 6,760.34
FTSE 250: down 2.2% at 15,773.43
AIM ALL-SHARE: down 0.9% at 788.14
GBP-USD: up at 1.6950
EUR-USD: down at 1.3533
GOLD: flat at USD1,272.59 an ounce
OIL (Brent): up at USD112.85 a barrel
--------
Other Top UK Corporate News
--------
Petra Diamonds shares jumped to the top of the FTSE 250 index after the company said it has recovered another exceptional 122.52 carat blue diamond at the Cullinan mine in South Africa. The diamond mining company with operations in Tanzania, Botswana and South Africa said the stone will require further analysis in order to assess its potential value, but once this is completed, it will make a decision on a sale plan for the stone. It said that the diamond will therefore not be sold until after the end of the company's current financial year, which ends on June 30.
----------
Tullow Oil said it has refinanced its USD330 million Norwegian exploration loan facility, increaing the facility to USD500 million and extending the loan availability to the end of 2017. The FTSE 100 oil and gas exploration company said the arrangement replaces a previous facility arranged by Spring Energy before it was acquired by Tullow Oil in January 2013. It was due to expire in December 2014.
----------
GlaxoSmithKline said a late stage study of its drug eltrombopag for the treatment of chronic immune thrombocytopenia in paediatric patients had met its primary endpoint. Immune thrombocytopenia is a bleeding disorder where the blood does not clot properly. The drug, which its marketed as Promacta in the US and Revolade in Europe, showed a statistically significant improvement in platelet counts compared to a placebo.
----------
AstraZeneca said late Thursday that the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes trials for a class of drugs including AstraZeneca's movantix treatment. Movantix is a mu-opioid receptor antagonist for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. Opioids assist with chronic pain relief by binding mu-receptors in the brain, but also bind nu-receptors in the bowel, which means patients taking opioids for chronic pain can develop opioid-induced constipation.
----------
UK women's clothing retailer Bonmarche Holdings reported strong profit and sales growth in its most recent financial year, driven by market share gains, price increases and growth in its online business. In its maiden results as a listed company, the clothing retailer targeting women over 50 years old reported a pretax profit of GBP11.2 million for the financial year ended March 29, up from GBP6.1 million a year earlier, as the company posted a 12% increase in revenues to GBP164.3 million, from GBP146.8 million. Like-for-like sales also grew strongly, up more than 10%. The retailer declared its first dividend of 2.1 pence per share for the year.
----------
AIM MOVERS
----------
SyQic is a big gainer after it said its main mobile streaming business, YooMob, booked revenue of GBP2.0 million in the first quarter to end-March, and had experienced encouraging trading in the two subsequent months, with total revenue of GBP1.6 million in April and May. SyQic expects the "upward trend" in revenue to continue during the rest of the year. Cientifica is also up after it entered into a development agreement with UK based Perpetuus Carbon Group in the hope of speeding up the production of its graphene products. Perpetuus produces nano surface modified graphenes. Under the collaboration Perpetuus will provide technical support for Cientifica's product development to bring them to market quicker. No financial details were disclosed. Tower Resources has lost two-thirds of its value after it failed to find hydrocarbons in early targets at the Welwitschia-1A well on the PEL0010 licence offshore Namibia, and had to stop drilling deeper due to spiralling costs. The well is being plugged and abandoned. ViaLogy is another big faller after it became a molecular diagnostic company by buying Premaitha for GBP10.5 million, although it had to write down the value of the energy services business it is trying to offload because it is taking longer than it hoped to find a "suitable" partner for that business. It said it would pay for Premaitha by issuing 95.5 million new shares at 11 pence each, and that it had raised GBP6.5 million by placing 59.1 million new shares at the same price. It also launched an open offer of up to 6.7 million more new shares at the same price. It is also planning a 100-for-1 share consolidation, because it thinks it will benefit from having fewer shares in issue and trading in pence rather than fractions of a pence. It will change its name to Premaitha Health. Transense Technologies is down after it said it now expects to post a loss before interest, tax, depreciation and amortisation for its current financial year, albeit a narrower loss than last year, after it experienced delays in getting some new orders. It said it expects its revenue in the year to end-June to be no less that GBP3.5 million, up from GBP1.5 million a year earlier, but that is lower that it had expected when it put out its interim results in February. The company had previously expected to breakeven at the Ebitda level in the current financial year, but said the revenue shortfall compared with previous expectations means it will now make a loss.
----------
Top Economics And General
----------
Sunni militants have captured at least one town in eastern Iraq, broadening their domination over portions of the country as they press south toward the capital Baghdad, reports said. Their lightning advances have sparked international fears that Iraq is falling apart, making room for the emergence of a radical enclave. Fighters from the radical Islamic State in Iraq and the Levant (ISIL), backed by local insurgents, seized the town of Jalula, 125 kilometres north-east of Baghdad, Dubai-based broadcaster Al Arabiya said. However, local officials said Jalula was under the control of Peshmerga - military troops of Kurdistan - after government forces abandoned their outposts in the town.
----------
The US is not considering sending troops into Iraq to stop advances by Islamist militants, a State Department spokeswoman said. Describing the situation as "alarming" and saying there has been a "clear structural breakdown" in Iraq, spokeswoman Jen Psaki said the US and Iraq "share a commitment to addressing threats from groups such as ISIL." Psaki spoke at a briefing after US President Barack Obama said his administration was "looking at all options" on how to respond to the latest violence in Iraq.
----------
Bank of England governor Mark Carney signalled that interest rate could rise sooner than forecast, due to strong economic growth. In a speech at the annual Mansion House in the City of London to financial and political leaders on Thursday, the governor said that interest rate "could happen sooner than markets currently expect." "There's already great speculation about the exact timing of the first rate hike and this decision is becoming more balanced. However, the decision would be dependent on data and is not a pre-set course", he added. There remains more spare capacity in the economy that would need to be used up first, he said.
----------
Fitch Ratings affirmed the sovereign ratings of the UK with 'stable' outlook, citing its favourable macroeconomic trends. The long-term ratings were maintained at 'AA+'. Strong GDP growth, falling unemployment and inflation close to the 2% target continued in the economy since the last review in December 2013, Fitch said.
----------
Fitch Ratings has also lowered South Africa's credit rating outlook to Negative from Stable, citing deterioration in growth prospects amid rising labor strike activity in the country.
----------
The Bank of Japan retained its monetary policy unchanged while raising its view on overseas growth. The policy board of the BoJ unanimously decided to increase the monetary base at an annual pace of about JPY60-JPY70 trillion as widely expected by economists. "Overseas economies -- mainly advanced economies -- are recovering, albeit with a lackluster performance still seen in part," the bank said. With regard to the Japan outlook, the bank said the economy is expected to continue a moderate recovery as a trend, while it will be affected by the subsequent decline in demand following the front-loaded increase prior to the consumption tax hike.
----------
EU Energy Commissioner Guenther Oettinger says he expects gas talks between Russia and Moscow to resume on Saturday. "My hope is that we can continue tomorrow," he told journalists on the margins of an EU energy ministers' meeting in Luxembourg, adding that he expects Ukraine and Russia to be represented by their energy ministers and the chiefs of their respective gas companies. He said he is flexible on the location, whether it be "Brussels or Berlin or Kiev or Moscow."
----------
Ukraine said late Thursday that separatists in eastern Ukraine had obtained heavy armour from neighbouring Russia. Pro-Russian militants had brought at least three tanks across the border, Interior Minister Arsen Avakov told journalists in Kiev. President Petro Poroshenko had voiced "extreme concern" over the tanks and the wider clashes in eastern Ukraine, in a phone call, said European Commission President Jose Manuel Barroso, speaking at a press conference in Georgia. Moscow made no immediate comment.
----------
Neymar's two goals, some help from the Japanese referee, and big support from the local fans have given hosts Brazil the perfect start to the World Cup. The 3-1 victory over Croatia in the tournament opener Thursday sparked widespread celebrations in the country, and coach Luiz Felipe Scolari is relieved that his team can book a place in the last 16 as early as Tuesday if they beat Mexico, and other results go their way. "This victory gives us a chance to breathe and another victory gives me room to breathe," Scolari said, describing his players as excellent.
---------
Afternoon Watchlist (all times British Summer Time)
---------

13:30 US Producer Price Index
14:55 US Reuters/Michigan Consumer Sentiment Index Preliminary

---------
Monday's Key UK Corporate Events
---------

Picton Property Income Full Year Results
F&C Global Smaller Companies Full Year Results
Majestic Wine Full Year Results
RM2 International Full Year Results

---------
Monday's Key Economic Events (all times British Summer Time)
---------

00:01 UK BoE Quarterly Bulletin
00:01 UK Rightmove House Price Index
06:00 Japan BoJ Monthly Economic Survey
10:00 EU Consumer Price Index
13:30 US NY Empire State Manufacturing Index
14:15 US Industrial Production
15:00 US NAHB Housing Market Index

---------

Contact: +44 203 668 7440; newsroom@alliancenews.com; @AllNewsTeam

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.